Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-24 5:23 pm Purchase |
2022-01-13 | 13G | Aclaris Therapeutics, Inc. ACRS |
BIOTECHNOLOGY VALUE FUND L P | 3,868,043 6.300% |
3,868,043 (New Position) |
Filing History |
| 2021-02-16 4:32 pm Purchase |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 2,676,100 6.240% |
462,244 (+20.88%) |
Filing History |
| 2021-02-12 3:18 pm Sale |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
EcoR1 Capital LLC | 1,509,812 3.500% |
-577,500 (-27.67%) |
Filing History |
| 2021-02-11 2:56 pm Purchase |
2021-02-05 | 13G | Aclaris Therapeutics, Inc. ACRS |
Foresite Capital Fund III L.P. | 6,612,181 13.700% |
4,381,241 (+196.39%) |
Filing History |
| 2021-02-11 07:29 am Sale |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 2,250,000 5.240% |
-250,000 (-10.00%) |
Filing History |
| 2021-02-10 8:48 pm Purchase |
2020-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS |
Renaissance Technologies LLC | 3,268,178 7.610% |
485,881 (+17.46%) |
Filing History |
| 2020-10-26 7:47 pm Purchase |
2020-10-20 | 13G | Aclaris Therapeutics, Inc. ACRS |
Foresite Capital Fund III L.P. | 2,230,940 5.200% |
2,230,940 (New Position) |
Filing History |
| 2020-10-26 4:49 pm Purchase |
2020-10-14 | 13G | Aclaris Therapeutics, Inc. ACRS |
Rock Springs Capital Management LP | 2,213,856 5.180% |
613,856 (+38.37%) |
Filing History |
| 2020-07-22 3:04 pm Sale |
2020-07-20 | 13G | Aclaris Therapeutics, Inc. ACRS |
MFN Partners, LP | 1,895,677 4.530% |
-2,104,323 (-52.61%) |
Filing History |
| 2020-07-10 10:39 am Sale |
2020-06-30 | 13G | Aclaris Therapeutics, Inc. ACRS |
BLACKROCK INC BLK |
1,047,816 2.500% |
-1,591,753 (-60.30%) |
Filing History |
| 2020-06-26 4:25 pm Purchase |
2020-06-17 | 13G | Aclaris Therapeutics, Inc. ACRS |
ADAGE CAPITAL PARTNERS GP LLC | 2,500,000 5.970% |
2,500,000 (New Position) |
Filing History |